NCHR and Consumer Groups Applaud Decision to Hold Amazon Responsible for Certain Hazardous Products

July 30, 2024: NCHR and other consumer groups’ joint press release expresses their support for the CPSC decision to hold Amazon responsible for certain hazardous products sold by third parties on their website. According to the Decision and Order, Amazon is a “distributor” of certain defective or non-compliant products and is therefore responsible for the illegal sale of those products. Amazon must submit plans to notify consumers about specific hazardous products and offer incentives to return or destroy the products.

Read More »

FDA’s agenda in limbo as Biden’s nominee stalls in Senate

Fox13, February 9, 2022: President Joe Biden’s pick to lead the Food and Drug Administration has stalled in the narrowly divided Senate, an unexpected setback that could delay decisions on electronic cigarettes and other high-profile health issues. Will all the publicity help Califf get confirmed, given the alternatives?

Read More »

Dr. Diana Zuckerman’s Statement on FDA’s Draft Guidance on Labeling for Breast Implants

October 23, 2019. The FDA’s draft includes the types of information that we have proposed to the FDA in recent months in our work with patient advocates and plastic surgeons.  The devil is in the details, so we look forward to working with the FDA to finalize these materials so that patients can make better informed decisions in the future than most women considering breast implants have been able to make.

Read More »